Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy.
Li YR, Zhou Y, Yu J, Zhu Y, Lee D, Zhu E, Li Z, Kim YJ, Zhou K, Fang Y, Lyu Z, Chen Y, Tian Y, Huang J, Cen X, Husman T, Cho JM, Hsiai T, Zhou JJ, Wang P, Puliafito BR, Larson SM, Yang L.
Li YR, et al. Among authors: fang y.
Mol Ther. 2024 Apr 6:S1525-0016(24)00221-1. doi: 10.1016/j.ymthe.2024.04.005. Online ahead of print.
Mol Ther. 2024.
PMID: 38584391
Free article.